Navina, an AI-enabled clinical intelligence platform for primary care providers, announced the close of a $55 million Series C funding round, bringing its total raise to $100 million.
Growth Equity at Goldman Sachs Alternatives led the round, with participation from existing investors Vertex Ventures Israel, ALIVE and Grove Ventures.
WHAT IT DOES
Navina offers providers, accountable care...
Healthcare B2B e-commerce platform Kyberlife has bagged $3 million in an investing round led by 5I Ventures. The sum was also raised from East Ventures, A2D Ventures, and NUS Alumni Ventures.
WHAT IT DOES
Founded in Singapore in 2021, the startup runs an online marketplace for sourcing critical healthcare equipment for use by academics, research laboratories, and other healthcare institutions. It...
Vuno invests $2M, sells lung AI in Japan to rival
Vuno has invested in and sold its lung disease diagnosis AI technology in Japan to its rival Korean company Coreline Soft.
The two companies recently entered into a strategic partnership to jointly raise their competitiveness in the growing global medical imaging AI segment.
Vuno invested 3.4 billion won ($2.3 million) in Coreline Soft, to which...
Foundation models with the ability to process and generate multi-modal data have transformed AI’s role in medicine. Nevertheless, researchers discovered that a major limitation of their reliability is hallucinations, where inaccurate or fabricated information can impact clinical decisions and patient safety, according to a study published in medRxiv.
In the study, researchers defined a medical...
Medibank now owns telehealth platform Medinet
ASX-listed private health insurer Medibank has completely acquired telehealth company Medinet.
The company initially made a A$10 million ($6 million) investment in the latter in 2022.
"The team at Medinet has some incredible capabilities in health system interoperability which will be pivotal to the connected experiences that we know will have a big...
Tech-enabled drug discovery company Insilico Medicine secured $110 million in an oversubscribed Series E funding round.
A large equity fund of Value Partners Group, an asset management firm in Asia, and new and existing investors participated in the round.
WHAT IT DOES
Massachusetts-based Insilico's proprietary generative AI platform, Pharma.AI, utilizes biology, clinical medicine, scientific...
Neuromod, a medical device company out of Dublin focused on treating tinnitus, secured €10 million ($10.9 million) in equity financing, expanding its Series B raise.
The raise builds on the company's €10.5 million ( $11.43 million) oversubscribed Series B financing in 2020.
Existing investors Fountain Healthcare Partners and Panakès Partners led the round.
WHAT IT DOES
Neuromod is a global...
Hinge Health, a digital musculoskeletal care platform, filed for an IPO on Monday with the U.S. Securities and Exchange Commission to go public under the symbol HNGE, despite recent stock market volatility due to uncertainty around U.S. trade policies.
The San Francisco-based company, founded in 2015, provides individuals with musculoskeletal conditions access to health coaches, orthopedic...
Hybrid musculoskeletal care provider Vori Health announced it has raised an oversubscribed $53 million in a Series B funding round.
NEA led the round with participation from Echo Health Ventures, Max Ventures, AlleyCorp and Intermountain Health's Intermountain Ventures.
WHAT IT DOES
Vori Health offers virtual and in-person musculoskeletal care. The company connects patients with specialty medical...
Digital chronic disease management platform Health2Sync has recently raised $20 million in a Series C funding round led by Taiwania Capital. Wistron, Pegatron, BE Health Ventures, ABIES Capital, and Cathay Venture also joined the round.
This latest investment brings its total capital raised since its founding in 2013 to over $30 million.
WHAT IT'S FOR
In a media release, the company said it...